Goldman Sachs’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-28,300
| Closed | -$6.14M | – | 6811 |
|
|
2021
Q1 | $6.14M | Buy |
+28,300
| New | +$5.32M | ﹤0.01% | 2955 |
|
|
2020
Q4 | – | Sell |
-16,600
| Closed | -$1.62M | – | 5833 |
|
|
2020
Q3 | $1.62M | Buy |
+16,600
| New | +$1.91M | ﹤0.01% | 3718 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$3.14M | – | 5681 |
|
|
2019
Q4 | $3.14M | Buy |
30,000
+8,100
| +37% | +$908K | ﹤0.01% | 3319 |
|
|
2019
Q3 | $2.52M | Buy |
+21,900
| New | +$3.32M | ﹤0.01% | 3391 |
|
|
2018
Q1 | – | Sell |
-30,000
| Closed | -$3.96M | – | 6532 |
|
|
2017
Q4 | $3.96M | Buy |
+30,000
| New | +$3.52M | ﹤0.01% | 3228 |
|
|
2017
Q1 | – | Sell |
-175,000
| Closed | -$19.6M | – | 7105 |
|
|
2016
Q4 | $19.6M | Buy |
+175,000
| New | +$21.1M | 0.01% | 1972 |
|
|
2016
Q3 | – | Sell |
-9,600
| Closed | -$879K | – | 7259 |
|
|
2016
Q2 | $879K | Buy |
9,600
+5,000
| +109% | +$421K | ﹤0.01% | 4308 |
|
|
2016
Q1 | $332K | Buy |
4,600
+1,400
| +44% | +$76.8K | ﹤0.01% | 5168 |
|
|
2015
Q4 | $222K | Sell |
3,200
-34,200
| -91% | -$2.79M | ﹤0.01% | 5617 |
|
|
2015
Q3 | $3.42M | Buy |
+37,400
| New | +$4.16M | ﹤0.01% | 3245 |
|
|
2014
Q2 | – | Sell |
-10,000
| Closed | -$594K | – | 7206 |
|
|
2014
Q1 | $594K | Buy |
+10,000
| New | +$595K | ﹤0.01% | 5130 |
|
Other funds holding GWPH
Goldman Sachs's GWPH Position: Q2 2021 in Review
Goldman Sachs sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 52,242 shares — an estimated $11.3M sold.
Goldman Sachs first reported a position in GWPH in Q1 2014 and held it in 28 quarters. The position peaked at $27.3M in Q4 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Goldman Sachs reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Goldman Sachs sold 52,242 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $11.3M.
- Goldman Sachs first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 28 quarters.
- Goldman Sachs's GW Pharmaceuticals Plc American Depositary Shares position peaked at $27.3M in Q4 2016.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.